RxDoctor Payments Data

Ashley Cocilova

Family · Flowood, MSNPI 1184038499

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (37.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Abbott accounts for 71.0% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $24,533, more than ten times the $2,289 reported in 2021. Among family clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$72,487in general payments, 2019–2025

Across 504 payments — averaging $143.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$51K
  • Spinal Simplicity, LLC$18K
  • Boston Scientific$972
  • Medtronic$540
  • AbbVie$467
  • Relievant Medsystems, Inc.$335
  • plus $477 from 14 others

What the payments were for

  • Consulting fees$7,30010%
  • Speaking & faculty fees$23,73733%
  • Travel & lodging$27,10937%
  • Food & beverage$12,74218%
  • Education$1,6002%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$72,487 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$177,108
Medicare patients
222
Services billed
2,727

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate59$45,633
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,160$31,166
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen681$22,326
Pregabalin363$10,041
Gabapentin553$7,941
SavellaMilnacipran Hcl11$5,220
Celecoxib87$4,167
Morphine Sulfate ErMorphine Sulfate172$3,816
Oxycodone Hcl163$2,914
Tizanidine Hcl299$2,496
Diclofenac Sodium87$2,333
Baclofen225$2,217
Tramadol Hcl ErTramadol Hcl41$2,165
Tramadol Hcl144$1,744
Cyclobenzaprine Hcl149$1,431

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$57$45,63359 claims
AbbVieSavella$467$5,22011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,007 family providers in Mississippi.

Other family in Flowood

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →